AAAAAA
Results: 1-25/44
Authors:
Lazarus, HM
Price, RS
Sorensen, J
Citation: Hm. Lazarus et al., Dangers of large exotic pets from foreign lands, J TRAUMA, 51(5), 2001, pp. 1014-1015
Authors:
Preti, RA
Lazarus, HM
Winter, J
Stadtmauer, EA
Nadasi, S
McMannis, J
Karandish, S
Jennis, A
Goldberg, SL
Pecora, AL
Citation: Ra. Preti et al., Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer, CYTOTHERAPY, 3(2), 2001, pp. 85-95
Authors:
Hahn, T
Wolff, SN
Czuczman, M
Fisher, RI
Lazarus, HM
Vose, J
Warren, L
Watt, R
McCarthy, PL
Citation: T. Hahn et al., The role of cytotoxic therapy with hematopoietic stem cell transplantationin the therapy of diffuse large cell B-Cell non-Hodgkin's lymphoma: An evidence-based review, BIOL BLOOD, 7(6), 2001, pp. 308-331
Authors:
Avigan, D
Pirofski, L
Lazarus, HM
Citation: D. Avigan et al., Vaccination against infectious disease following hematopoietic stem cell transplantation, BIOL BLOOD, 7(3), 2001, pp. 171-183
Authors:
Winston, DJ
Lazarus, HM
Beveridge, RA
Hathorn, JW
Gucalp, R
Ramphal, R
Chow, AW
Ho, WG
Horn, R
Feld, R
Louie, TJ
Territo, MC
Blumer, JL
Tack, KJ
Citation: Dj. Winston et al., Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients, CLIN INF D, 32(3), 2001, pp. 381-390
Authors:
Lawrence, JB
Yomtovian, RA
Hammons, T
Masarik, SR
Chongkolwatana, V
Creger, RJ
Manka, A
Lazarus, HM
Citation: Jb. Lawrence et al., Lowering the prophylactic platelet transfusion threshold: A prospective analysis, LEUK LYMPH, 41(1-2), 2001, pp. 67-76
Authors:
Lazarus, HM
Citation: Hm. Lazarus, Transplant registries: Guiding clinical decisions and improving outcomes -The Horowitz et al article reviewed, ONCOLOGY-NY, 15(5), 2001, pp. 663-664
Authors:
Vose, JM
Zhang, MJ
Rowlings, PA
Lazarus, HM
Bolwell, BJ
Freytes, CO
Pavlovsky, S
Keating, A
Yanes, B
van Besien, K
Armitage, JO
Horowitz, MM
Citation: Jm. Vose et al., Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry, J CL ONCOL, 19(2), 2001, pp. 406-413
Authors:
Bennett, JM
Young, MS
Liesveld, JL
Paietta, E
Miller, KB
Lazarus, HM
Marsh, RD
Friedenberg, WR
Saba, HT
Hayes, FA
Dewald, GW
Hiddemann, W
Rowe, JM
Citation: Jm. Bennett et al., Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group study, AM J HEMAT, 66(1), 2001, pp. 23-27
Authors:
Miller, CB
Rowlings, PA
Zhang, MJ
Jones, RJ
Piantadosi, S
Keating, A
Armitage, JO
Calderwood, S
Harris, RE
Klein, JP
Lazarus, HM
Linker, CA
Sobocinski, KA
Weisdorf, D
Horowitz, MM
Citation: Cb. Miller et al., The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia, EXP HEMATOL, 29(11), 2001, pp. 1336-1346
Authors:
Vesole, DH
Simic, A
Lazarus, HM
Citation: Dh. Vesole et al., Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts, BONE MAR TR, 28(8), 2001, pp. 725-735
Authors:
Ratanatharathorn, V
Ayash, L
Lazarus, HM
Fu, J
Uberti, JP
Citation: V. Ratanatharathorn et al., Chronic graft-versus-host disease: clinical manifestation and therapy, BONE MAR TR, 28(2), 2001, pp. 121-129
Authors:
Winston, DJ
Antin, JH
Wolff, SN
Bierer, BE
Small, T
Miller, KB
Linker, C
Kaizer, H
Lazarus, HM
Petersen, FB
Cowan, MJ
Ho, WG
Wingard, JR
Schiller, GJ
Territo, MC
Jiao, J
Petrarca, MA
Tonetta, SA
Citation: Dj. Winston et al., A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation, BONE MAR TR, 28(2), 2001, pp. 187-196
Authors:
Rowe, JM
Lazarus, HM
Citation: Jm. Rowe et Hm. Lazarus, Genetically haploidentical stem cell transplantation for acute leukemia, BONE MAR TR, 27(7), 2001, pp. 669-676
Authors:
Flinn, IW
Lazarus, HM
Citation: Iw. Flinn et Hm. Lazarus, Monoclonal antibodies and autologous stem cell transplantation for lymphoma, BONE MAR TR, 27(6), 2001, pp. 565-569
Authors:
Lazarus, HM
Loberiza, FR
Zhang, MJ
Armitage, JO
Ballen, KK
Bashey, A
Bolwell, BJ
Burns, LJ
Freytes, CO
Galeg, RP
Gibson, J
Herzig, RH
LeMaistre, CF
Marks, D
Mason, J
Miller, AM
Milone, GA
Pavlovsky, S
Reece, DE
Rizzo, JD
van Besien, K
Vose, JM
Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR), BONE MAR TR, 27(4), 2001, pp. 387-396
Authors:
Koc, ON
Lazarus, HM
Citation: On. Koc et Hm. Lazarus, Mesenchymal stem cells: heading into the clinic, BONE MAR TR, 27(3), 2001, pp. 235-239
Authors:
Pecora, AL
Lazarus, HM
Stadtmauer, EA
Winter, J
Van Vliet, A
Berry, D
Gray, R
Jennis, A
Goldberg, S
Cooper, BW
Preti, R
Citation: Al. Pecora et al., Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer, BONE MAR TR, 27(12), 2001, pp. 1245-1253
Authors:
Laughlin, MJ
Barker, J
Bambach, B
Koc, ON
Rizzieri, DA
Wagner, JE
Gerson, SL
Lazarus, HM
Cairo, M
Stevens, CE
Rubinstein, P
Kurtzberg, J
Citation: Mj. Laughlin et al., Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors., N ENG J MED, 344(24), 2001, pp. 1815-1822
Authors:
Schenkein, DP
Koc, Y
Alcindor, T
Stadtmauer, EA
Miller, KB
Cooper, BW
Partridge, AH
Lazarus, HM
Citation: Dp. Schenkein et al., Treatment of primary resistant or relapsed multiple myeloma with high-dosechemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor, BIOL BLOOD, 6(4A), 2000, pp. 448-455
Authors:
Kornblau, S
Benson, AB
Catalano, R
Champlin, RE
Engelking, C
Field, M
Ippoliti, C
Lazarus, HM
Mitchell, E
Rubin, J
Stiff, PJ
Vokes, E
Wadler, S
Citation: S. Kornblau et al., Management of cancer treatment-related diarrhea: Issues and therapeutic strategies, J PAIN SYMP, 19(2), 2000, pp. 118-129
Authors:
Koc, ON
Gerson, SL
Cooper, BW
Laughlin, M
Meyerson, H
Kutteh, L
Fox, RM
Szekely, EM
Tainer, N
Lazarus, HM
Citation: On. Koc et al., Randomized cross-over trial of progenitor-cell mobilization: High-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF, J CL ONCOL, 18(9), 2000, pp. 1824-1830
Authors:
Koc, ON
Gerson, SL
Cooper, BW
Dyhouse, SM
Haynesworth, SE
Caplan, AI
Lazarus, HM
Citation: On. Koc et al., Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy, J CL ONCOL, 18(2), 2000, pp. 307-316
Authors:
Davies, SM
Ramsay, NKC
Klein, JP
Weisdorf, DJ
Bolwell, B
Cahn, JY
Camitta, BM
Gale, RP
Giralt, S
Heilmann, C
Henslee-Downey, PJ
Herzig, RH
Hutchinson, R
Keating, A
Lazarus, HM
Milone, GA
Neudorf, S
Perez, WS
Powles, RL
Prentice, HG
Schiller, G
Socie, G
Vowels, M
Wiley, J
Yeager, A
Horowitz, MM
Citation: Sm. Davies et al., Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J CL ONCOL, 18(2), 2000, pp. 340-347
Authors:
Friedman, J
Lazarus, HM
Koc, ON
Citation: J. Friedman et al., Autologous CD34(+) enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation, BONE MAR TR, 26(8), 2000, pp. 831-836